Treatment for spasmodic dysphonia: limitations of current approaches
Open accessThe DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
PURPOSE OF REVIEW: Although botulinum toxin injection is the gold standard for treatment of spasmodic dysphonia, surgical approaches aimed at providing long-term symptom control have been advancing over recent years. RECENT FINDINGS: When surgical approaches provide greater long-term benefits to symptom control, they also increase the initial period of side effects of breathiness and swallowing difficulties. Recent analyses of quality-of-life questionnaires in patients undergoing regular injections of botulinum toxin demonstrate that a large proportion of patients have limited relief for relatively short periods due to early breathiness and loss-of-benefit before reinjection. SUMMARY: Most medical and surgical approaches to the treatment of spasmodic dysphonia have been aimed at denervation of the laryngeal muscles to block symptom expression in the voice, and have both adverse effects as well as treatment benefits. Research is needed to identify the central neuropathophysiology responsible for the laryngeal muscle spasms in order target treatment towards the central neurological abnormality responsible for producing symptoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“while SD typically requires botulinum toxin injections to alleviate involuntary spasms, MTD responds well to voice therapy alone (12–16).”
From A deep learning approach for acoustic-based identification of muscle tension dysphonia and spasmodic dysphonia (2026) · cites this paper as [12]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“while SD typically requires botulinum toxin injections to alleviate involuntary spasms, MTD responds well to voice therapy alone (12–16).”
From A deep learning approach for acoustic-based identification of muscle tension dysphonia and spasmodic dysphonia (2026) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Validation of an instrument to measure voice-related quality of life (V-RQOL)
Hogikyan, N. D., & Sethuraman, G. (1999) · Journal of Voice · doi:10.1016/s0892-1997(99)80010-1 · Cited by 1,143
Simpson, D. M., Blitzer, A., Brashear, A., Comella, C., Dubinsky, R., Hallett, M., Jankovic, J., Karp, B., Ludlow, C. L., Miyasaki, J. M., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000311389.26145.95 · Cited by 618
Self-citationLong-Distance Retrograde Effects of Botulinum Neurotoxin A
Antonucci, F., Rossi, C., Gianfranceschi, L., Rossetto, O., & Caleo, M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0375-08.2008 · Cited by 450
Blitzer, A., Brin, M. F., & Stewart, C. F. (1998) · The Laryngoscope · doi:10.1097/00005537-199810000-00003 · Cited by 391
Recurrent Laryngeal Nerve Section for Spastic Dysphonia
Dedo, H. H. (1976) · Annals of Otology, Rhinology & Laryngology · doi:10.1177/000348947608500405 · Cited by 271
Morrison, La, R., Belisle, G. M., Cb, P., & Nichol, H. (1983) · PubMed · Cited by 200
Research priorities in spasmodic dysphonia
Ludlow, C. L., Adler, C. H., Berke, G. S., Bielamowicz, S. A., Blitzer, A., Bressman, S. B., Hallett, M., Jinnah, H. A., Juergens, U., Martin, S. B., et al. (2008) · Otolaryngology–Head and Neck Surgery · doi:10.1016/j.otohns.2008.05.624 · Cited by 181
Self-citationIs voice therapy an effective treatment for dysphonia? A randomised controlled trial
MacKenzie, K., Millar, A., Wilson, J. A., Sellars, C., & Deary, I. J. (2001) · BMJ · doi:10.1136/bmj.323.7314.658 · Cited by 173
Double‐blind controlled study of botulinum toxin in adductor spasmodic dysphonia
Truong, D. D., Rontal, M., Rolnick, M., Aronson, A. E., & Mistura, K. (1991) · The Laryngoscope · doi:10.1288/00005537-199106000-00010 · Cited by 166
Berke, G. S., Verneil, A., Blackwell, K. E., Jackson, K. S., Gerratt, B. R., & Sercarz, J. A. (1999) · Annals of Otology, Rhinology & Laryngology · doi:10.1177/000348949910800302 · Cited by 151
Aronson, A. E., Brown, J. R., Litin, E. M., & Pearson, J. S. (1968) · Journal of Speech and Hearing Disorders · doi:10.1044/jshd.3303.219 · Cited by 142
Simonyan, K., Tovar-Moll, F., Ostuni, J., Hallett, M., Kalasinsky, V. F., Lewin-Smith, M. R., Rushing, E. J., Vortmeyer, A. O., & Ludlow, C. L. (2008) · Brain · doi:10.1093/brain/awm303 · Cited by 138
Self-citationWarrick, P., Dromey, C., Irish, J. C., Durkin, L., Pakiam, A., & Lang, A. (2000) · The Laryngoscope · doi:10.1097/00005537-200008000-00028 · Cited by 136
Classification and Approach to Patients with Functional Voice Disorders
Koufman, J. A., & Blalock, P. D. (1982) · Annals of Otology, Rhinology & Laryngology · doi:10.1177/000348948209100409 · Cited by 133
Recent Advances in Phonosurgery
Isshiki, N. (2009) · Folia Phoniatrica et Logopaedica · doi:10.1159/000264334 · Cited by 122
Hogikyan, N. D., Wodchis, W. P., Terrell, J. E., Bradford, C. R., & Esclamado, R. M. (2000) · Journal of Voice · doi:10.1016/s0892-1997(00)80083-1 · Cited by 111
Abductor laryngeal dystonia: A series treated with botulinum toxin
Blitzer, A., Brin, M. F., Stewart, C., Aviv, J. E., & Fahn, S. (1992) · The Laryngoscope · doi:10.1288/00005537-199202000-00011 · Cited by 107
Botulinum Toxin Type A for Treating Voice Tremor
Adler, C. H., Bansberg, S. F., Hentz, J. G., Ramig, L. O., Buder, E. H., Witt, K., Edwards, B. W., Krein-Jones, K., & Caviness, J. N. (2004) · Archives of Neurology · doi:10.1001/archneur.61.9.1416 · Cited by 103
Adductor Spastic Dysphonia as a Sign of Essential (Voice) Tremor
Aronson, A. E., & Hartman, D. E. (1981) · Journal of Speech and Hearing Disorders · doi:10.1044/jshd.4601.52 · Cited by 99
Chhetri, D. K., Mendelsohn, A. H., Blumin, J. H., & Berke, G. S. (2006) · The Laryngoscope · doi:10.1097/01.mlg.0000201990.97955.e4 · Cited by 95
Effects of Botulinum Toxin on Pathophysiology in Spasmodic Dysphonia
Bielamowicz, S., & Ludlow, C. L. (2000) · Annals of Otology, Rhinology & Laryngology · doi:10.1177/000348940010900215 · Cited by 91
Self-citationMidline Lateralization Thyroplasty for Adductor Spasmodic Dysphonia
Isshiki, N., Yamamoto, Y., Tsuji, D. H., & Iizuka, Y. (2000) · Annals of Otology Rhinology & Laryngology · doi:10.1177/000348940010900214 · Cited by 89
Thyroplasty for Adductor Spasmodic Dysphonia: Further Experiences
Isshiki, N., Haji, T., Yamamoto, Y., & Mahieu, H. F. (2001) · The Laryngoscope · doi:10.1097/00005537-200104000-00011 · Cited by 82
An Evaluation of Laryngeal Muscle Activation in Patients with Voice Tremor
Koda, J., & Ludlow, C. L. (1992) · Otolaryngology · doi:10.1177/019459989210700510 · Cited by 77
Self-citationMarked depression and anxiety in patients with functional dysphonia
Willinger, U., Völkl-Kernstock, S., & Aschauer, H. N. (2005) · Psychiatry Research · doi:10.1016/j.psychres.2003.07.007 · Cited by 77
Bielamowicz, S., Bidus, K., Squire, S., & Ludlow, C. L. (2001) · Annals of Otology, Rhinology & Laryngology · doi:10.1177/000348940111000503 · Cited by 69
Self-citationPaniello, R. C., Barlow, J., & Serna, J. S. (2008) · The Laryngoscope · doi:10.1097/mlg.0b013e31815e8be0 · Cited by 68
Barkmeier, J., Case, J. L., & Ludlow, C. L. (2001) · Journal of Communication Disorders · doi:10.1016/s0021-9924(00)00039-3 · Cited by 67
Self-citationAcoustic Measures of Symptoms in Abductor Spasmodic Dysphonia
Edgar, J. D., Sapienza, C. M., Bidus, K., & Ludlow, C. L. (2001) · Journal of Voice · doi:10.1016/s0892-1997(01)00038-8 · Cited by 65
Self-citationLaryngeal Muscle Activity During Speech Breaks in Adductor Spasmodic Dysphonia
Nash, E. A., & Ludlow, C. L. (1996) · The Laryngoscope · doi:10.1097/00005537-199604000-00017 · Cited by 65
Self-citationEssential Vocal Tremor: Clinical Characteristics and Response to Therapy
Massey, E. W., & Paulson, G. W. (1985) · Southern Medical Journal · doi:10.1097/00007611-198503000-00020 · Cited by 63
Nakamura, K., Muta, H., Watanabe, Y., et al. (2008) · Acta Oto-Laryngologica · doi:10.1080/00016480801965019 · Cited by 62
Recurrent Laryngeal Nerve Avulsion for Treatment of Spastic Dysphonia
Netterville, J. L., Stone, R. E., Zealear, D. L., et al. (1991) · Annals of Otology Rhinology & Laryngology · doi:10.1177/000348949110000102 · Cited by 60
Pastor, Á. M., Moreno‐López, B., de la Cruz, R. R., & Delgado-Garcia, J. M. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00200-5 · Cited by 60
Acoustic Variations in Adductor Spasmodic Dysphonia as a Function of Speech Task
Sapienza, C. M., Walton, S., & Murry, T. (1999) · Journal of Speech, Language, and Hearing Research · doi:10.1044/jslhr.4201.127 · Cited by 56
The treatment of essential voice tremor with botulinum toxin A: A longitudinal case report
Warrick, P., Dromey, C., Irish, J. C., & Durkin, L. C. (2000) · Journal of Voice · doi:10.1016/s0892-1997(00)80086-7 · Cited by 56
Long‐Term Results of Type II Thyroplasty for Adductor Spasmodic Dysphonia
Chan, S. W., Baxter, M., Oates, J., & Yorston, A. (2004) · The Laryngoscope · doi:10.1097/00005537-200409000-00019 · Cited by 56
Study of Spastic Dysphonia Using Videofiberoptic Laryngoscopy
Parnes, S. M., Lavorato, A. S., & Myers, E. N. (1978) · Annals of Otology Rhinology & Laryngology · doi:10.1177/000348947808700305 · Cited by 54
Essential vocal tremor: clinical characteristics and response to therapy.
Massey, E. W., & Paulson, G. W. (1985) · PubMed · Cited by 52
Long-Term Follow-up of Recurrent Laryngeal Nerve Avulsion for the Treatment of Spastic Dysphonia
Jewett, B. S., Stone, R. E., Weed, D. T., Rainey, C. L., Ossoff, R. H., Zealear, D. L., & Netterville, J. L. (1996) · Annals of Otology Rhinology & Laryngology · doi:10.1177/000348949610500802 · Cited by 50
Intrinsic Laryngeal Muscle Activity in a Spastic Dysphonia Patient
Shipp, T., Izdebski, K., Reed, C. G., & Morrissey, P. (1985) · Journal of Speech and Hearing Disorders · doi:10.1044/jshd.5001.54 · Cited by 49
Adductor Spastic Dysphonia: 1 1/2 Years after Recurrent Laryngeal Nerve Resection
Aronson, A., & DeSanto, L. W. (1981) · Annals of Otology Rhinology & Laryngology · doi:10.1177/000348948109000102 · Cited by 49
Laryngeal Framework Surgery in the Management of Spasmodic Dysphonia: Preliminary Report
Tucker, H. M. (1989) · Annals of Otology Rhinology & Laryngology · doi:10.1177/000348948909800111 · Cited by 46
Adductor Muscle Activity Abnormalities in Abductor Spasmodic Dysphonia
Cyrus, C. B., Bielamowicz, S. A., Evans, F. J., & Ludlow, C. L. (2001) · Otolaryngology · doi:10.1067/mhn.2001.112572 · Cited by 43
Self-citationMoreno‐López, B., de la Cruz, R. R., Pastor, Á. M., et al. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00199-1 · Cited by 41
Long-Term Effects of Botulinum Toxin Injections in Spasmodic Dysphonia
Davidson, B. J., & Ludlow, C. L. (1996) · Annals of Otology Rhinology & Laryngology · doi:10.1177/000348949610500106 · Cited by 40
Self-citationGenack, S. H., Woo, P., Colton, R. H., & Goyette, D. (1993) · Otolaryngology · doi:10.1177/019459989310800309 · Cited by 34
Watts, C. R., Truong, D. D., & Nye, C. (2007) · Journal of Neural Transmission · doi:10.1007/s00702-007-0757-x · Cited by 34
Long-term results of recurrent laryngeal nerve resection for adductor spasmodic dysphonia
Fritzell, B., Hammarberg, B., Schiratzki, H., et al. (1993) · Journal of Voice · doi:10.1016/s0892-1997(05)80348-0 · Cited by 34
Experiences with Recurrent Laryngeal Nerve Section for Spastic Dysphonia
Fritzell, B., Feuer, E., Haglund, S., KNUTSSON, E., & Schiratzki, H. (2009) · Folia Phoniatrica et Logopaedica · doi:10.1159/000265645 · Cited by 33
Sanuki, T., & Isshiki, N. (2009) · Acta Oto-Laryngologica · doi:10.3109/00016480802620639 · Cited by 31
Vocal aging and adductor spasmodic dysphonia: Response to botulinum toxin injection
Cannito, M. P., Kahane, J. C., & Chorna, L. (2008) · Clinical Interventions in Aging · doi:10.2147/cia.s1416 · Cited by 30
Long-Term Botulinum Toxin Dose Consistency for Treatment of Adductor Spasmodic Dysphonia
Holden, P. K., Vokes, D. E., Taylor, M. B., Till, J. A., & Crumley, R. L. (2007) · Annals of Otology Rhinology & Laryngology · doi:10.1177/000348940711601204 · Cited by 30
An electromyographic study of recurrent laryngeal nerve conduction and its clinical applications
Atkins, J. P. (1973) · The Laryngoscope · doi:10.1288/00005537-197305000-00015 · Cited by 30
Shaw, G. Y., Sechtem, P. R., & Rideout, B. (2003) · Annals of Otology Rhinology & Laryngology · doi:10.1177/000348940311200403 · Cited by 30
Tsuji, D. H., Chrispim, F. S., Imamura, R., Sennes, L. U., & Hachiya, A. (2006) · Brazilian Journal of Otorhinolaryngology · doi:10.1016/s1808-8694(15)30066-5 · Cited by 30
Remacle, M., Plouin‐Gaudon, I., Lawson, G., & Abitbol, J. (2005) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-004-0897-7 · Cited by 27
Management of Supraglottic Squeeze in Adductor Spasmodic Dysphonia: A New Technique
Young, N., & Blitzer, A. (2007) · The Laryngoscope · doi:10.1097/mlg.0b013e318124a97b · Cited by 27
Klein, A. M., Stong, B. C., Wise, J., DelGaudio, J. M., Hapner, E. R., & Johns, M. M. E. (2008) · Otolaryngology · doi:10.1016/j.otohns.2008.06.013 · Cited by 26
Carbon dioxide laser‐assisted thyroarytenoid myomectomy
Woo, P. (1990) · Lasers in Surgery and Medicine · doi:10.1002/lsm.1900100507 · Cited by 25
Botulinum toxin A injection under electromyographic guidance for treatment of spasmodic dysphonia
Casserly, P., & Timon, C. I. (2007) · The Journal of Laryngology & Otology · doi:10.1017/s0022215107007852 · Cited by 23
Selective Denervation: Reinnervation for the Control of Adductor Spasmodic Dysphonia
Allegretto, M., Morrison, M. D., Rammage, L., & Lau, D. P. C. (2003) · The Journal of Otolaryngology · doi:10.2310/7070.2003.40431 · Cited by 23
Dosage changes in patients with long‐term botulinum toxin use for laryngeal dystonia
Bırkent, H., Maronian, N. C., Waugh, P. F., Meratı, A. L., Perkel, D. J., & Hıllel, A. D. (2009) · Otolaryngology · doi:10.1016/j.otohns.2008.10.033 · Cited by 22
Radiofrequency thyroarytenoid myothermy for treatment of adductor spasmodic dysphonia: how we do it
Kim, H. S., Choi, H. ‐., Lim, J., Choi, Y., & Lim, S.-E. (2008) · Clinical Otolaryngology · doi:10.1111/j.1749-4486.2008.01777.x · Cited by 19
Respiratory distress after recurrent laryngeal nerve sectioning for adductor spastic dysphonia
Salassa, J. R., DeSanto, L. W., & Aronson, A. (1982) · The Laryngoscope · doi:10.1288/00005537-198203000-00004 · Cited by 16
Tsuji, D. H., Chrispim, F. S., Imamura, R., Sennes, L. U., & Hachiya, A. (2006) · Revista Brasileira de Otorrinolaringologia · doi:10.1590/s0034-72992006000200019 · Cited by 14
Dr. Trevelyan and Mr. Treves: Sherlock Holmes and the Elephant Man
MASSEY, J. M., & Massey, E. W. (1985) · Southern Medical Journal · doi:10.1097/00007611-198507000-00020 · Cited by 10
Doxorubicin Chemomyectomy: Effects on Evoked Vocal Fold Tension and Mucosal Wave
Goding, G. S., & Pernell, K. J. (2000) · Annals of Otology Rhinology & Laryngology · doi:10.1177/000348940010900311 · Cited by 8
Efficacy of a Portable, Audible‐Only Electromyography Device in the Treatment of Spasmodic Dysphonia
Jeffcoat, B. T., & Schweinfurth, J. M. (2008) · The Laryngoscope · doi:10.1097/mlg.0b013e3181639b7e · Cited by 3
Research works printed but not linked: 3
- Parnes, 1978, Ann Otol, 87, 322
- Morrison, 1983, J Otolaryngol, 12, 302
- Davidson, 1996, Otolaryngol Head Neck Surg, 105, 33
Cited by
Differential diagnosis of muscle tension dysphonia and spasmodic dysphonia
Roy, N. (2010) · Current Opinion in Otolaryngology & Head & Neck Surgery · doi:10.1097/moo.0b013e328339376c · Cited by 60
The Mayo Clinic Arizona Spasmodic Dysphonia Experience: A Demographic Analysis of 718 Patients
Patel, A. B., Bansberg, S. F., Adler, C. H., Lott, D. G., & Crujido, L. (2015) · Annals of Otology, Rhinology & Laryngology · doi:10.1177/0003489415588557 · Cited by 60
Spasmodic dysphonia: introductory phonetic analyses
Reid, E. W., & Nobriga, C. V. (2023) · Clinical Linguistics & Phonetics · doi:10.1080/02699206.2022.2096483 · Cited by 5
“Treatment attempts have included acupuncture, hypnotism, psychotherapy, speech therapy, surgery, and pharmacological intervention (Levine et al., 1979; Ludlow, 2009).”
BackgroundZhou, Z., Cheng, Y., Ren, Q., Li, Y., Yuanyue, X., Kang, J., Lu, C., & Ge, P. (2026) · Frontiers in Digital Health · doi:10.3389/fdgth.2026.1690534 · Cited by 1
“This diagnostic ambiguity is concerning given their fundamentally different treatment pathways: while SD typically requires botulinum toxin injections to alleviate involuntary spasms, MTD responds well to voice therapy alone (12 – 16).”
Metadata
- Authors
- Ludlow, C. L.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Ludlow, Christy L
- ORCID
- Ludlow, Christy L
- Venue
- Current Opinion in Otolaryngology & Head and Neck Surgery
- Published
- 2009-06
- Volume
- 17
- Issue
- 3
- Pages
- 160-165
- ISSN
- 1068-9508 (ISSN-L)
- PMC
- PMC2763389
- OpenAlex
- W1989533854
- Cited by
- 84
- References
- 70
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 2 · 2023: 3 · 2022: 3 · 2021: 4 · 2020: 4 · 2019: 6 · 2018: 3 · 2017: 4 · 2016: 6 · 2015: 6 · 2014: 8 · 2013: 9 · 2012: 11
- FWCI
- 3.99
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Current Opinion in Otolaryngology & Head & Neck Surgery (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke (Z01NS002980)
- Topics
- Health Sciences › Health Professions › Speech and Hearing › Voice and Speech Disorders
- Health Sciences › Medicine › Clinical Neurology › Botulinum Toxin and Related Neurological Disorders
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory and Cough-Related Research
- Keywords
- spasmodic dysphonia, botulinum toxin injection, laryngeal surgery, denervation, breathiness, dysphagia, quality of life, treatment limitations
- MeSH terms
- Humans, Injections, Intramuscular, Laryngeal Muscles, Microsurgery, Muscle Denervation, Outcome and Process Assessment, Health Care, Recurrent Laryngeal Nerve, Botulinum Toxins, Type A, Dysphonia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.